Delivery Order SPE2DR25D7068-SPE2DR26F5BX5
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Varenicline 1 mg tablets (56-count packaging) with a contract value of $1,222.62. This firm fixed-price delivery order is set to be completed by October 22, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a non-set-aside competitive procurement, reflecting the agency's confidence in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Varenicline 0.5 mg tablets (56-count units) under a firm fixed-price contract with a ceiling value of $5,061.75. The award, issued on May 22, 2025, represents a non-set-aside, competitively awarded delivery order with an ultimate completion date of May 23, 2025. This order will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company maintains its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Varenicline 1 mg tablets (56-count packaging) under a firm fixed-price contract valued at $1,650.82. The contract, effective May 8, 2025, with an ultimate completion date of May 9, 2025, represents a non-set-aside competitive award for pharmaceutical distribution to support federal medical procurement needs. Performance will be executed from the contractor's corporate office location in...
- The Defense Logistics Agency awarded a $1,007.15 delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Varenicline 1 mg tablets (56-count packages). This contract represents a firm fixed-price delivery order with an ultimate completion date of August 1, 2025, and carries no set-aside designation, indicating it was competitively awarded. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the company's corporate headquarters location. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Varenicline 1 mg tablets (56-count packages) valued at $1,637.64. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 14, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation and represents a child contract under the vendor's...
- The Defense Logistics Agency awarded a $1,155.00 delivery order to AmerisourceBergen Drug Corp for Varenicline 1 mg tablets (56-count packaging) with a firm fixed price structure. The order was competitively awarded without set-aside designation and is scheduled for completion by October 29, 2025. AmerisourceBergen will perform this delivery from its corporate headquarters in Conshohocken, Pennsylvania, where the company serves as a major pharmaceutical distributor supporting federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 15, 2025, for the supply of Varenicline 1 mg tablets (56-count packaging) with a ceiling value of $2,360.02 and a firm fixed price structure. This is a non-set-aside competitively awarded contract with an ultimate completion date of July 16, 2025. The order is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and represents a small-value transaction...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Varenicline 1mg tablets in a 56-count package at a ceiling value of $3,841.20. This firm fixed-price delivery order represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor that serves as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a $1,827.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 56 tablets of Varenicline 1 mg on September 24, 2025, with completion expected by September 25, 2025. This is a non-set-aside competitive award issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The company, headquartered in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,996.74 to AmerisourceBergen Drug Corp for the supply of Varenicline 1 mg tablets in a quantity of 56 units. The contract was awarded on May 22, 2025, with an ultimate completion date of May 23, 2025, and utilizes firm fixed pricing with no set-aside designation. This delivery order represents a competitively awarded transaction under the company's existing federal contract vehicle, with performance to be fulfilled at...
- SPE2DR25D7068Indefinite Delivery Contract
- SPE2DR25D7068-SPE2DR26F5BX5Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Varenicline 1 mg tablets (56-count packaging) with a ceiling value of $1,720.86 under firm fixed price terms. The award, issued on December 12, 2025, with an ultimate completion date of December 15, 2025, represents a non-competitive delivery order with no set-aside designation. Performance will be executed from the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion prime vendor agreement running through December 2026 that provides comprehensive pharmaceutical and medical supply support to military healthcare systems globally. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen Drug Corp supplies a diverse portfolio of medications and medical commodities to support Defense Health Agency and other government healthcare customers through this flexible contract vehicle, which enables the company to respond to recurring pharmaceutical requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 12/11/25 |